Results 11 to 20 of about 446,090 (169)

Serological evidence of louse-borne relapsing fever in northern Kenya

open access: yesTravel Medicine and Infectious Disease
Background: Tick- and louse-borne relapsing fever are highly-neglected, vector-borne diseases caused by diverse Borrelia species. Presently, there are no data available on the endemicity of tick- and louse-borne relapsing fever spirochetes in Kenya. Here,
Flavia Reyer   +7 more
doaj   +4 more sources

Louse-borne relapsing fever (Borrelia recurrentis infection). [PDF]

open access: yesEpidemiol Infect, 2019
AbstractLouse-borne relapsing fever (LBRF) is an epidemic disease with a fascinating history from Hippocrates’ times, through the 6th century ‘Yellow Plague’, to epidemics in Ireland, Scotland and England in the 19th century and two large Afro-Middle Eastern pandemics in the 20th century.
Warrell DA.
europepmc   +7 more sources

Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. [PDF]

open access: yesPLoS ONE, 2009
Borrelia recurrentis, the etiologic agent of louse-borne relapsing fever in humans, has evolved strategies, including antigenic variation, to evade immune defence, thereby causing severe diseases with high mortality rates.
Sonja Grosskinsky   +7 more
doaj   +3 more sources

Borreliae Part 2: Borrelia Relapsing Fever Group and Unclassified Borrelia [PDF]

open access: yesBiology, 2021
Borreliae of the relapsing fever group (RFG) are heterogenous and can be divided mainly into three groups according to vectors, namely the soft-tick-borne relapsing fever (STBRF) Borreliae, the hard-tick-borne relapsing fever (HTBRF) Borreliae, the louse-
Giusto Trevisan   +6 more
doaj   +3 more sources

A mathematical model for the transmission of louse-borne relapsing fever [PDF]

open access: yesEuropean Journal of Applied Mathematics, 2017
We present a detailed derivation and analysis of a model consisting of seven coupled delay differential equations for louse-borne relapsing fever (LBRF), a disease transmitted from human to human by the body louse Pediculus humanus humanus. Delays model the latency stages of LBRF in humans and lice, which vary in duration from individual to individual,
Alsheri, Ahuod, Gourley, Stephen
core   +6 more sources

Tick-Borne Relapsing Fever Spirochetes in the Americas

open access: yesVeterinary Sciences, 2016
Relapsing fever spirochetes are tick- and louse-borne pathogens that primarily afflict those in impoverished countries. Historically the pathogens have had a significant impact on public health, yet currently they are often overlooked because of the ...
Job E. Lopez   +3 more
doaj   +2 more sources

Louseborne Relapsing Fever among East African Refugees, Italy, 2015

open access: yesEmerging Infectious Diseases, 2016
During June 9–September 30, 2015, five cases of louseborne relapsing fever were identified in Turin, Italy. All 5 cases were in young refugees from Somalia, 2 of whom had lived in Italy since 2011.
Anna Lucchini   +13 more
doaj   +2 more sources

Population Structure of East African Relapsing Fever Borrelia spp.

open access: yesEmerging Infectious Diseases, 2010
Differentiation of endemic East African tick-borne relapsing fever Borrelia duttonii spirochetes from epidemic louse-borne relapsing fever (LBRF) B. recurrentis spirochetes into different species has been questioned.
Sally J. Cutler   +2 more
doaj   +2 more sources

Tick-borne Relapsing Fever in Children in the North-west of Iran, Qazvin [PDF]

open access: yesPrague Medical Report, 2015
Relapsing fever is caused by the Borrelia species of spirochetes. Louse-borne epidemics of the disease may happen but the endemic disease is generally transmitted to humans by the bite of an infected tick (Ornithodorus).
Parviz Ayazi   +4 more
doaj   +2 more sources

Ancient <i>Borrelia</i> genomes document the evolutionary history of louse-borne relapsing fever. [PDF]

open access: yesScience
Several bacterial pathogens have transitioned from tick-borne to louse-borne transmission, which often involves genome reduction and increasing virulence. However, the timing of such transitions remains unclear.
Swali P   +31 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy